No abstract available
Keywords:
anthracycline cardiotoxicity; cardiotoxicity; cardio‐oncology; sunitinib cardiotoxicity; trastuzumab cardiotoxicity.
MeSH terms
-
Animals
-
Antineoplastic Agents / adverse effects*
-
Cytoprotection
-
Exercise Therapy*
-
Heart Diseases / chemically induced*
-
Heart Diseases / metabolism
-
Heart Diseases / prevention & control*
-
Humans
-
Molecular Targeted Therapy
-
Myocardium / metabolism
-
Protective Agents / therapeutic use*
-
Risk Assessment
-
Risk Factors
-
Signal Transduction / drug effects
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Protective Agents